The global demand for casein glycomacropeptide is anticipated to increase at around 4.8% to 6.8% CAGR during the forecast period from 2022 and 2032. Growth in the market is driven by rising usage of casein glycomacropeptide in functional foods and beverages as well as dietary supplements.
| Report Attribute | Details |
| Casein Glycomacropeptide Market Projected Growth Rate (2022-2032) | 4.8% - 6.8% CAGR |
As the preference for healthy and nutritious diets continues to escalate, demand for food products and dietary supplements containing casein glycomacropeptide is expected to rise at a substantial pace during the forthcoming years.
Casein glycomacropeptide is a bioactive peptide with multiple functions, derived from milk. It is released in whey during the making of cheese and has become one of the commonly used food derived bioactive peptide across food and medical industries.
In recent years, casein glycomacropeptide has emerged as an ideal protein substitute in Phenylketonuria. It is rich in branched amino-acids and thus provides numerous health benefits. It contains small traces of phenylalanine, tryptophan, and tyrosine and is therefore an excellent choice for people suffering from phenylketonuria. It is for this reason that casein glycomacropeptide is being extensively used for making various medical food products to treat patients with phenylketonuria.
Similarly, growing health awareness among people coupled with rising usage of casein glycomacropeptide in a variety of dietary supplements and food products is anticipated to boost market growth during the forecast period.
Rising prevalence of phenylketonuria across the world, growing demand for nutritional foods and supplements, increasing health awareness among consumers, and rapid expansion of end use verticals are some of the major factors driving the global casein glycomacropeptide market.
Casein glycomacropeptide has become an ideal protein source for patients suffering from phenylketonuria, a genetic condition that causes an increase in the level of phenylalanine (an amino acid) in the body. Thus, rapid increase in the number of patients suffering from phenylketonuria is expected to create sales prospects for casein glycomacropeptide during the forecast period. According to the National PLU Alliance, phenylketonuria affects between 1 in 10,000 and 1 in 20,000 depending on the country of origin.
Similarly, increasing consumption of casein glycomacropeptide based foods and medical supplements by patients suffering from hepatic and tyrosinemia disorders is providing a strong thrust to market growth. This increase in consumption of casein glycomacropeptide products is due to low content of aromatic amino acids in casein glycomacropeptide.
Food and beverage manufacturers are increasingly using casein glycomacropeptide on account of its nutrition-rich profile and antimicrobial activity to manufacture nutritional products that could even be consumed by phenylketonuria patients. Rising production and consumption of these food products will therefore continue to boost casein glycomacropeptide market during the upcoming period.
Another key factor fueling the adoption of casein glycomacropeptide in nutritional food products and dietary supplements is its (casein glycomacropeptide’s) good taste. It enables manufacturers to develop nutritional food products without compromising the flavor of the end products.
In addition to this, growing consumer awareness about the benefits of consuming casein glycomacropeptide especially across developing regions is expected to provide tailwinds to market growth during the assessment period. Casein glycomacropeptide has the ability to improve gut and bone health due to the presence of various neutral amino acids including threonine and isoleucine. It is also a rich source of sialic acid which plays a key role in cognitive and neuronal development of individuals.
Despite various end uses of casein glycomacropeptide, there are various factors that are likely to challenge market growth during the assessment period. Some of these factors are the poor availability of casein glycomacropeptide products across various emerging economies and low consumer awareness regarding the health benefits of casein glycomacropeptide.
North America was the largest market for casein glycomacropeptide in 2022 and the trend is expected to continue into the forecast period owing to rising consumption of dietary supplements, high consumer awareness levels, and heavy presence of leading market players.
Demand for casein glycomacropeptide is especially high across the United States due to rising usage of casein glycomacropeptide in nutritional and dietary products and increasing prevalence of Phenylketonuria. According to the National PKU Association, there are around 16,500 people living with PKU in the United States. This is positively impacting market growth in the region.
According to Future Market Insights, the casein glycomacropeptide market in Asia Pacific is expected to grow at a considerable pace during the forecast period from 2022 and 2032, owing to the growing health awareness among people, rising demand for healthy and nutritional foods, and rapid expansion of food and beverage industry across countries like China and India.
Some of the key participants present in the global casein glycomacropeptide market include S.A Pharmachem Pvt Ltd, Arla Foods Ingredients Group P/S, Agropur Ingredients, American Dairy Products Institute, Nestlé Health Science S.A. among others.
These key players are continuously focusing on introducing novel products to woo more and more customers. Furthermore, they have adopted various organic and inorganic growth strategies such as partnerships, collaborations, move towards online shopping platforms, and establishment of new manufacturing facilities across attractive regions to expand their global footprint.
| Report Attribute | Details |
| Growth Rate | CAGR of 4.8% - 6.8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By End Use:
By Region:
FMI projects the global casein glycomacropeptide market to expand at around 4.8% to 6.8% CAGR throughout the forecast period between 2022 and 2032
As per FMI, North America is forecast to remain the most lucrative market for casein glycomacropeptide during the forecast period.
S.A Pharmachem Pvt Ltd, Arla Foods Ingredients Group P/S, Agropur Ingredients, and American Dairy Products Institute are some prominent casein glycomacropeptide manufacturers
Casein Glycomacropeptide Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
